Intermountain Health, the largest nonprofit healthcare provider in the Intermountain West region, struck a multi-year collaboration with a young generative AI startup this month. The health system is ...
Icotrokinra demonstrated superior skin clearance at Weeks 16 and 24 compared to deucravacitinib and similar adverse event ...
Cancer patients' messages about radiology/pathology reports: Insights for AI. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract does not include a full text component ...
InBrain Pharma to Present Long-Term Follow-Up Clinical Data from Its Phase I/II DIVE-I Trial in Parkinson’s Disease at the MDS 2025 Conference ...
Investment led by UPMC Enterprises, with participation from MemorialCare Innovation Fund, Rex Health Ventures, Tampa General Hospital Ventures, Memorial Hermann Health System, Frist Cressey Ventures, ...
Marengo Therapeutics, Inc., a clinical-stage biotechnology company pioneering novel approaches for precision immunotherapy in oncology and inflammation and immunology (I&I), will present a ...
SAN FRANCISCO, Feb. 11, 2025 /PRNewswire/ -- The vast majority of clinical data abstractors believe AI would save them time, effort and cost, but concerns about data quality without human oversight ...
Salt Lake City-based Intermountain Health is partnering with health AI company Layer Health to streamline how it manages clinical data. The multi-year collaboration, announced in a June 17 news ...
The central promise of precision medicine is to provide right-sized and personalized care, patient by patient, instead of hewing to a singular clinical pathway for all patients who have a particular ...
NUCLIDIUM AG, a clinical-stage radiopharmaceutical company developing a proprietary copper-based theranostic platform, today announced that the company’s abstract featuring first clinical data from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback